PTC Therapeutics, Inc.
PTCT
$66.71
$2.223.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -949.05% | 124.51% | -107.48% | 1,415.24% | 38.22% |
| Total Depreciation and Amortization | 16.14% | 46.50% | 5.01% | 6.76% | 4.29% |
| Total Amortization of Deferred Charges | 2.62% | 0.99% | 1.00% | -2.61% | 2.33% |
| Total Other Non-Cash Items | 58.37% | -156.90% | -59.71% | 590.50% | -159.55% |
| Change in Net Operating Assets | 207.35% | -407.63% | 60.27% | -215.04% | 272.04% |
| Cash from Operations | 48.31% | -13.66% | -106.70% | 2,999.96% | 61.03% |
| Capital Expenditure | 31.09% | -161.58% | 23.61% | 54.23% | -621.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 112.71% | 31.97% | -130.26% | -167.30% | 743.76% |
| Cash from Investing | 111.74% | 31.37% | -128.90% | -168.87% | 727.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | 271.38% | 324.89% | -74.85% | -40.50% | 4,519.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | 100.00% |
| Cash from Financing | 1,887.67% | 284.22% | -57.91% | -64.45% | 250.17% |
| Foreign Exchange rate Adjustments | 261.53% | -144.63% | 151.96% | 162.33% | -201.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 189.98% | 25.07% | -166.06% | 174.16% | 298.46% |